1. Home
  2. BHC vs WEN Comparison

BHC vs WEN Comparison

Compare BHC & WEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHC
  • WEN
  • Stock Information
  • Founded
  • BHC N/A
  • WEN 1969
  • Country
  • BHC Canada
  • WEN United States
  • Employees
  • BHC N/A
  • WEN N/A
  • Industry
  • BHC Biotechnology: Pharmaceutical Preparations
  • WEN Restaurants
  • Sector
  • BHC Health Care
  • WEN Consumer Discretionary
  • Exchange
  • BHC Nasdaq
  • WEN Nasdaq
  • Market Cap
  • BHC 2.6B
  • WEN 3.1B
  • IPO Year
  • BHC N/A
  • WEN N/A
  • Fundamental
  • Price
  • BHC $6.25
  • WEN $14.72
  • Analyst Decision
  • BHC Hold
  • WEN Hold
  • Analyst Count
  • BHC 5
  • WEN 19
  • Target Price
  • BHC $7.20
  • WEN $18.50
  • AVG Volume (30 Days)
  • BHC 1.5M
  • WEN 4.9M
  • Earning Date
  • BHC 04-30-2025
  • WEN 05-01-2025
  • Dividend Yield
  • BHC N/A
  • WEN 6.79%
  • EPS Growth
  • BHC N/A
  • WEN N/A
  • EPS
  • BHC N/A
  • WEN 0.95
  • Revenue
  • BHC $9,625,000,000.00
  • WEN $2,246,492,000.00
  • Revenue This Year
  • BHC $4.76
  • WEN $1.63
  • Revenue Next Year
  • BHC $2.05
  • WEN $3.90
  • P/E Ratio
  • BHC N/A
  • WEN $15.49
  • Revenue Growth
  • BHC 9.91
  • WEN 2.98
  • 52 Week Low
  • BHC $3.96
  • WEN $13.72
  • 52 Week High
  • BHC $11.46
  • WEN $20.65
  • Technical
  • Relative Strength Index (RSI)
  • BHC 31.59
  • WEN 43.25
  • Support Level
  • BHC $6.91
  • WEN $14.45
  • Resistance Level
  • BHC $7.45
  • WEN $15.50
  • Average True Range (ATR)
  • BHC 0.27
  • WEN 0.36
  • MACD
  • BHC -0.08
  • WEN -0.07
  • Stochastic Oscillator
  • BHC 0.00
  • WEN 24.11

About BHC Bausch Health Companies Inc.

Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

About WEN Wendy's Company (The)

The Wendy's Company is the second-largest burger quick-service restaurant, or QSR, chain in the United States by systemwide sales, with $12.3 billion in 2023, narrowly edging Burger King ($11.5 billion) and clocking in well behind wide-moat McDonald's ($53.1 billion). After divestitures of Tim Hortons (2006) and Arby's (2011), the firm manages just the burger banner, generating sales across a footprint that spanned almost 7,157 total stores in 30 countries as of year-end 2023. Wendy's generates revenue from the sale of hamburgers, chicken sandwiches, salads, and fries throughout its company-owned footprint, through franchise royalty and marketing fund payments remitted by its franchisees, which account for 94% of stores, and through franchise flipping and advisory fees.

Share on Social Networks: